Sankala Group’s Organon & Co OGN Stock Holding History

Sankala Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-190	Closed	-$1.39K	–	573
2025 Q4	$1.39K	Buy	+190	New	+$1.5K	﹤0.01%	516

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Sankala Group's OGN Position: Q1 2026 in Review

Sankala Group sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 190 shares — an estimated $1.39K sold.

Sankala Group first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $1.39K in Q4 2025. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Sankala Group reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
Sankala Group sold 190 Organon & Co shares in Q1 2026, an estimated $1.39K.
Sankala Group first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
Sankala Group's Organon & Co position peaked at $1.39K in Q4 2025.
606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.